Veeva is a technology company that connects pharmaceutical companies with clinical trial sponsors operating under the guise of Salesforce cloud.
Earnings are on June 1st and the stock typically gaps down. Luckily, there is major support going back to 2019 at $137. That would price it at around a 30 forward PE in 2 years. I would like to see it consolidate around...
